Pharmaceutical Business Review
Anonymous User | Login

Cerus, Grifols Extends INTERCEPT Blood System Distribution To Italy

Published: 26-May-2009

Cerus and Grifols have entered into an agreement to extend Grifols’ Intercept platelet and plasma distribution to Italy. The Intercept blood system inactivates a broad range of viruses, bacteria and parasites that may contaminate donated blood components, including emerging pathogens such as west nile virus, chikungunya and influenza virus.

Claes Glassell, President and CEO of Cerus, said: “we are pleased to broaden and further strengthen our relationship with Grifols, one of the largest pharmaceutical companies in Spain and the largest European plasma fractionator.”

“Building on our success to date, we look forward to working with Grifols in Italy to increase adoption of Intercept platelets and plasma,” he added.

Riccardo Vanni, Managing Director of Grifols Italia, said: “the Intercept technology perfectly complements Grifols’ transfusion line of products in Italy and is a good fit in terms of our marketing and sales organization.”

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Almac

Drug Development Solutions ...

STARLIMS

Benefits for Life Science Labs ...

Parenteral Drug Association (PDA)

Pharmaceutical Information and Education Services ...

Burkert Fluid Control Systems

Fluid and Gas Control Systems ...

IMCOR

LIMS and Laboratory Informatics Consultancy ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

Cerus Corporation

Cerus Corporation (Cerus) is a biopharmaceutical company engaged in the development and ...

Gen-Probe Incorporated

Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marke ...

Haemonetics Corporation

Haemonetics Corporation (Haemonetics) is engaged in the development, manufacture and ma ...

Pall Corporation

Pall Corporation (Pall) is a filtration, separation and purification company which manu ...

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address